These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 8093581)
1. Depression and dementia in Parkinson's disease. Catecholamine changes in the locus ceruleus, a basis for therapy. Chan-Palay V Adv Neurol; 1993; 60():438-46. PubMed ID: 8093581 [No Abstract] [Full Text] [Related]
2. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression. Chan-Palay V; Asan E J Comp Neurol; 1989 Sep; 287(3):373-92. PubMed ID: 2570794 [TBL] [Abstract][Full Text] [Related]
5. Effects of depression and Parkinson's disease on cognitive functioning. Norman S; Tröster AI; Fields JA; Brooks R J Neuropsychiatry Clin Neurosci; 2002; 14(1):31-6. PubMed ID: 11884652 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of depressed dementia or demented depression]. Azorin JM Encephale; 1994 Jun; 20 Spec No 2():281-4. PubMed ID: 8088247 [No Abstract] [Full Text] [Related]
7. [Severe therapy refractory depression as initial manifestation of Parkinson disease]. Amann B; Erfurth A; Back T; Grunze H Psychiatr Prax; 1999 Jan; 26(1):45-7. PubMed ID: 10087578 [TBL] [Abstract][Full Text] [Related]
8. Morphological alterations of the synapses in the locus coeruleus in Parkinson's disease. Baloyannis SJ; Costa V; Baloyannis IS J Neurol Sci; 2006 Oct; 248(1-2):35-41. PubMed ID: 16753180 [TBL] [Abstract][Full Text] [Related]
9. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease. Meco G; Bernardi S Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377 [TBL] [Abstract][Full Text] [Related]
11. Behind the iron mask: the mental changes of Parkinson's disease. Waddell PA; Donaldson IM N Z Med J; 1990 Oct; 103(899):478-9. PubMed ID: 2216132 [No Abstract] [Full Text] [Related]
12. Parkinson's disease; modern treatment. Tolosa E Minn Med; 1973 Jun; 56(6):497-502. PubMed ID: 4575903 [No Abstract] [Full Text] [Related]
13. An open study with reversible MAO-A inhibitors in complicated Parkinson's disease. Ruggieri S; Fabbrini G; Bramante L; DePandis F; Stocchi F; Barbanti P; Vacca L; Manfredi M Adv Neurol; 1996; 69():595-8. PubMed ID: 8615185 [No Abstract] [Full Text] [Related]
14. [Evidence-based therapeutic algorithms in the treatment of depression, dementia and psychosis in Parkinson's disease]. Krüger R; Weiss D MMW Fortschr Med; 2011 Apr; 153(14):29-32; quiz 33. PubMed ID: 21966866 [No Abstract] [Full Text] [Related]
15. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857 [TBL] [Abstract][Full Text] [Related]
16. Sertraline for the treatment of depression in Parkinson's disease. Meara J; Hobson P Mov Disord; 1998 May; 13(3):622. PubMed ID: 9613775 [No Abstract] [Full Text] [Related]
17. Antidepressants and psychosis in Parkinson disease: a case series. Voon V; Fox S; Butler TR; Lang AE Int J Geriatr Psychiatry; 2007 Jun; 22(6):601-4. PubMed ID: 17450623 [No Abstract] [Full Text] [Related]
18. [Pseudopheochromocytoma in Parkinson disease and depression]. Jähnel M Psychiatr Prax; 2003 May; 30 Suppl 2():S64-5. PubMed ID: 14509040 [TBL] [Abstract][Full Text] [Related]